Biostatisticians play a critical role in the advancement of new medicines at Pfizer. The right candidate will partner with clinicians, clinical pharmacologists, translational medicine, and other scientists to support drug development in Pfizers Early Clinical Development (ECD) unit. The statistician will support the development of innovative and efficient plans for developing new medicines in a variety of therapeutic areas. ECD supports early clinical development for immunology and inflammation indications developed by Pfizer immunology and inflammation research unit. He/she will be involved in the design, analysis, and reporting of clinical protocols covering early clinical development from first in human through registration. He/she will provide statistical expertise on regulatory submissions and ensure the quality and appropriateness of submission deliverables.
The qualified candidate must have a M.S. in Statistics or Biostatistics and a minimum of three years of experience in applying statistics in a pharmaceutical or related industry or a Ph.D. in Statistics or Biostatistics.
Ideally, the candidates experience would include exposure to the design and analysis of clinical studies in both early and late stage clinical development. The preferred candidate will have excellent statistical knowledge with the ability to apply this to scientific and clinical problems and experience with modeling and simulation in early clinical development and experience in using Bayesian methods to scientific research.
The preferred candidate will have strong computational skills in R, S-plus, or SAS and other statistical applied software systems such as Winbugs. Prior experience providing statistical support to clinical studies in immunology and inflammation is a plus. Must be able to explain statistical techniques and considerations to non-statisticians. Good communication skills and the ability to work collaboratively with the clinical project team are required.
Pfizer reports payments and other transfers of value to health care providers as required by federal and state transparency laws and implementing regulations. These laws and regulations require Pfizer to provide government agencies with information such as a health care providers name, address and the type of payments or other value received, generally for public disclosure. Subject to further legal review and statutory or regulatory clarification, which Pfizer intends to pursue, reimbursement of recruiting expenses for licensed physicians may constitute a reportable transfer of value under the federal transparency law commonly known as the Sunshine Act. Therefore, if you are a licensed physician who incurs recruiting expenses as a result of interviewing with Pfizer that we pay or reimburse, your name, address and the amount of payments made currently will be reported to the government. If you have questions regarding this matter, please do not hesitate to contact your Talent Acquisition representative.
EEO & Employment Eligibility
Pfizer is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Pfizer also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Pfizer is an E-Verify employer. #LI-PFEN (Other) (United States of America)
Pfizer is an equal opportunity employer and complies with all applicable equal employment opportunity legislation in each jurisdiction in which it operates.
PerkinElmer - Boston, MA
Akebia Therapeutics - Cambridge, MA
Fortinet - Boston, MA
Carbon Black - Waltham, MA
Boston University - Boston, MA